We are waiting on near term approvals for the US (GRAS), Canada, Japan, Taiwan and Korea, aren't we? Maybe they already have what they need in Japan, though, as Epoca is on sale now. Did that include food approval though? (What do you make of this,
http://translate.google.com/translat...knumber-1-1-1/ It came out in August, and does not look like the Epoca deal to me, but I have waited in vain for further reports of this. Tradepia is a company I believe, but the name is used a lot in Japan.)
The market seems to have gone in to an uncertain state on Blis shares, presumably while everyone waits to see if the news shows Blis to be already undersold or oversold. Will we get clear news, though, or will we have to wait for next March?
Personally, I would quite like to hear how things like Nature's Plus sell (via numerous distributors) compared to Bioguard (via concentrated outlets), but I suspect that will not be clear. It would also be interesting to hear about food. (Is chewing gum a food, requiring GRAS?) NZ and Australia have food approval now, and marketers often like to test in smaller markets - against which, is Blis a winter product here? Throat Guard yoghurt might sell at airports though, or chewing gum.
And, of course, it would be great to hear of advances in Europe or Asia.
Meanwhile, preference dividends this Friday, I think.